Post-diagnosis diet, nutrition and cancer prognosis

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC

Breastfeeding after breast cancer is safe

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared to placebo and fulvestrant

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy